THE EFFECT OF SOLUTION FORMULATION ON THE STABILITY AND SURFACE INTERACTIONS OF FACTOR-VIII DURING PLASMA FRACTIONATION

Cohn, Strong, Hughes, Mulford, Ashworth, Melin, Taylor, Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids, J Am Chem Soc, 68, pp. 459-475, (1946)

Morrison, Edsall, Miller, Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from fraction I of human plasma, J Am Chem Soc, 70, pp. 3103-3108, (1948)

Fowell, Stable fibrinogen solutions and methods for producing same, (1958)

Wagner, McLester, Smith, Brinkhouse, Purification of antihemophilic factor (factor VIII) by amino acid precipitation, Thromb Diath Haemorrh, 11, pp. 64-74, (1964)

Hershgold, Pool, Pappenhagan, The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma

characterisation and further data on preparation and clinical trial, J Lab Clin Med, 67, pp. 23-32, (1966)

Johnson, Karpatkin, Newman, Preparation and clinical experience with antihemophilic factor concentrates, Thromb Diath Haemorrh, 35, pp. 49-59, (1969)

Hynes, Owen, Bowie, Thompson, Citrate stabilisation of chromatography purified factor VIII, Blood, 34, pp. 601-609, (1969)

Newman, Johnson, Karpatkin, Puszkin, Methods for the production of clinically effective intermediate and high purity factor VIII concentrates, Br J Haematol, 21, pp. 1-20, (1971)

Penick, Brinkhouse, RELATIVE STABILITY OF PLASMA ANTIHEMOPHILIC FACTOR (AHF) UNDER DIFFERENT CONDITIONS OF STORAGE*, The American Journal of the Medical Sciences, 232, pp. 434-442, (1956)

Cohn, Strong, Hughes, Mulford, Ashworth, Melin, Taylor, Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids, J Am Chem Soc, 68, pp. 459-475, (1946)

Morrison, Edsall, Miller, Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from fraction I of human plasma, J Am Chem Soc, 70, pp. 3103-3108, (1948)

Fowell, Stable fibrinogen solutions and methods for producing same, (1958)

Wagner, McLester, Smith, Brinkhouse, Purification of antihemophilic factor (factor VIII) by amino acid precipitation, Thromb Diath Haemorrh, 11, pp. 64-74, (1964)

Hershgold, Pool, Pappenhagan, The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma

characterisation and further data on preparation and clinical trial, J Lab Clin Med, 67, pp. 23-32, (1966)

Johnson, Karpatkin, Newman, Preparation and clinical experience with antihemophilic factor concentrates, Thromb Diath Haemorrh, 35, pp. 49-59, (1969)

Hynes, Owen, Bowie, Thompson, Citrate stabilisation of chromatography purified factor VIII, Blood, 34, pp. 601-609, (1969)

Newman, Johnson, Karpatkin, Puszkin, Methods for the production of clinically effective intermediate and high purity factor VIII concentrates, Br J Haematol, 21, pp. 1-20, (1971)

Penick, Brinkhouse, RELATIVE STABILITY OF PLASMA ANTIHEMOPHILIC FACTOR (AHF) UNDER DIFFERENT CONDITIONS OF STORAGE*, The American Journal of the Medical Sciences, 232, pp. 434-442, (1956)